Warren Buffett fit · Wonderful businesses at fair prices
Is TG Therapeutics, Inc. (TGTX) a Warren Buffett Stock?
Low Buffett fit - meets only 2/9 criteria; valuation, moat, or financial health flags risk.
49/100
DMixed signals
2/9 criteria passed
+8 sector-quality lift. Top-quintile within its sector on 4 of 5 quality metrics. Raw pillar score 41 → lifted to 49 before grade derivation.
Warren Buffett's Criteria, Applied to TGTX
ROIC ≥ 15%
key11.1%
Gross margin ≥ 40%
key83.0%
Owner earnings yield ≥ 5%
key-0.4%
5y profitable
keyNo
Net Debt / EBITDA ≤ 3
2.0x
Revenue CAGR ≥ 8%
-
EPS CAGR ≥ 8%
-
FCF / Net income ≥ 0.8
-0.1x
Debt / Equity ≤ 1
1.3x
How TGTX Scores on Other Strategies
Live Financial Snapshot
Market cap
$5.81B
P/E (TTM)
12.4x
ROIC (TTM)
11.13%
Gross margin
83.04%
Other Warren Buffett fit reports
Frequently Asked Questions
What is TGTX's Warren Buffett fit score?
TGTX scores 49/100 on our Warren Buffett fit engine - grade D. Low Buffett fit - meets only 2/9 criteria; valuation, moat, or financial health flags risk.
Does Warren Buffett actually own TGTX?
Our score is computed from financial fundamentals against Warren Buffett's published criteria. We don't claim that Warren Buffett personally owns or recommends TGTX.
How often is this score updated?
TGTX's Warren Buffett fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Key terms in this analysis
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Warren Buffett personally owns or recommends TGTX.